CClinicalTrials.gg
RecruitingNCT05733403Updated Oct 23, 2023

Comparison of Hemodynamic Results of Two Different Fluid Managements

An interventional study of isotonic solution and Noradrenaline in Perioperative Fluid Management, sponsored by Istanbul University. Recruiting at 1 site in Turkey. Open to female participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-10-23.

Sponsored by Istanbul University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Apr 2022, registered Oct 2022).
  • Started Apr 2022; still recruiting 4 years 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
Female
01

Study summary

In the reduction mammoplasty operations performed in the Plastic and Reconstructive surgery operating room in our clinic, the female patient group, who does not have co-morbidities and does not exceed middle age, is followed by infusion of crystalloid at a constant rate of 4 ml/kg. If the mean arterial pressure (MAP) is \<65 mmHg, it is treated with fluid boluses, and in cases where no response is obtained, with noradrenaline boluses. However, in this process, frequent and severe hypotensive episodes are observed, especially after removal of more than a few kilograms of breast tissue. In these hypotensive episodes, factors other than the blood volume lost with the tissue may also play a role. For this reason, we aimed to evaluate the iNOS levels by assuming that the blood levels of "inducible nitric oxide synthetase" (iNOS), which is stored in large amounts in adipose tissues and has been shown to play a role in lipid metabolism, may increase with the manipulation of breast tissue, and accordingly increased nitric oxide may lead to hypotension.

Read the detailed description

The main purpose of intraoperative fluid therapy is to optimize intravascular volume, mean arterial pressure (MAP) and cardiac output, while ensuring tissue perfusion, while not causing dehydration and fluid overload in the patient. While hypovolemia may cause problems such as organ perfusion disorders and ischemia; Hypervolemia may lead to pulmonary edema, cardiac load, prolonged need for mechanical ventilation and susceptibility to related infections. Although fluid management in the perioperative period has been extensively studied in many studies, a standard practice has not been established. The amount considered restrictive in some studies may be liberal in others. In recent years, the use of dynamic parameters, which are formed as a result of cardiopulmonary interactions and whose high sensitivity and specificity have been proven by many studies, has been increasing day by day for the evaluation of intravascular volume. Pulse pressure variation(PPV) and stroke volume variation(SVV) are two of these dynamic parameters. The pulse contour cardiac output (FloTrac) system, which is a fairly newly developed method that calculates cardiac output and stroke volume directly from the arterial waveform, is used for measurement without the need for calibration.

In the reduction mammoplasty operations performed in the Plastic and Reconstructive surgery operating room in our clinic, the female patient group, who does not have co-morbidities and does not exceed middle age, is followed by infusion of crystalloid at a constant rate of 4 ml/kg. If the mean arterial pressure (MAP) is \<65 mmHg, it is treated with fluid boluses, and in cases where no response is obtained, with noradrenaline boluses. However, in this process, frequent and severe hypotensive episodes are observed, especially after removal of more than a few kilograms of breast tissue. In these hypotensive episodes, factors other than the blood volume lost with the tissue may also play a role. For this reason, we aimed to evaluate the iNOS levels by assuming that the blood levels of "inducible nitric oxide synthetase" (iNOS), which is stored in large amounts in adipose tissues and has been shown to play a role in lipid metabolism, may increase with the manipulation of breast tissue, and accordingly increased nitric oxide may lead to hypotension.

02

Conditions studied

  • Perioperative Fluid Management

Keywords

  • fluid therapy
  • hemodynamic parameters
  • The pulse contour cardiac output system
  • inducible nitric oxide synthetase
03

In context

Lead sponsor

Istanbul University is the lead sponsor of 496 studies on the registry; 79 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 1 (20%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  1. Volunteering to participate in the study
  2. ASA classification 1 or 2
  3. The patients who will undergo reduction mammoplasty operation

Exclusion criteria

Exclusion Criteria:

  1. Being under the age of 18 or over the age of 65
  2. Presence of serious hypertension
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Active comparator
    Stroke Volume Variation (SVV) Group

    When SVV value ≥ 14%, 250cc isotonic will be given within 10min. 250cc isotonic boluses will be repeated until the SVV drops below 14%. If MAP\< 65 mmHg despite the SVV falling below 14%, a bolus of 4mcg noradrenaline(NA) will be administered. During the operation, if the SVV is below 14% and the MAP is \< 65mmHg, a bolus of 4mcg NA will be administered. Intraoperative balance, amount of bleeding, number of fluid boluses and NA administrations, total additional fluid and NA amount, total number of hypotensive episodes will be recorded. The times when the breast tissue was removed, the weights of the removed tissues and the amount of bleeding will be recorded. Basal and 3 more arterial blood gases will be taken when the breast tissue is removed and early postoperatively, and Hgb, lactate, and base excess values will be recorded. iNOS values in blood will be recorded after basal iNOS and breast tissue are removed. The creatinine value will be recorded on the 1st postoperative day.

    Drug: isotonic solution · Drug: Noradrenaline

  • Active comparator
    Mean Arterial Pressure (MAP) Group

    If MAP value under below 65mmHg, 250ml isotonic will be given within 10 min. However, if MAP is still below 65mmHg, a bolus of 4mcg NA will be administered, if no response, 4mcg NA will be repeated. If MAP falls below 65mmHg again, 250 ml isotonic will be administered again in 10 min; if it does not improve, 4mcg of NA will be given iv. Intraoperative balance, amount of bleeding, number of fluid boluses and NA administrations, total additional fluid and NA amount, total number of hypotensive episodes will be recorded. The times when the breast tissue was removed, the weights of the removed tissues and the amount of bleeding will be recorded. Basal and 3 more arterial blood gases will be taken when the breast tissue is removed and early postoperatively, and Hgb, lactate, and base excess values will be recorded. iNOS values in blood will be recorded after basal iNOS and breast tissue are removed. The creatinine value will be recorded on the 1st postoperative day.

    Drug: isotonic solution · Drug: Noradrenaline

Interventions

  • Drugisotonic solution

    Isotonic solutions are IV fluids that have a similar concentration of dissolved particles as blood.

    Also known as: 0,9% NaCl

  • DrugNoradrenaline

    Noradrenaline itself is classified as a sympathomimetic drug: its effects when given by intravenous injection of increasing heart rate and force and constricting blood vessels make it very useful for treating medical emergencies that involve critically low blood pressure.

    Also known as: Norepinephrine

06

What researchers measure

Primary outcomes

  1. Cardiac index

    Cardiac index (CI) is a haemodynamic parameter that relates the cardiac output (CO) from left ventricle in one minute to body surface area (BSA),thus relating heart performance to the size of the individual. The unit of measurement is litres per minute per square metre (L/min/m2).

    Time frame: during surgery

Secondary outcomes

  1. Number of bolus administrations of noradrenaline

    For the MAP group, if MAP is still below 65 mmHg despite a bolus of 250ml isotonic fluid, a bolus of 4mcg noradrenaline will be administered, if no response, 4mcg noradrenaline will be repeated. For the SVV Group, a 4 mcg bolus of noradrenaline will be given if MAP\< 65 mmHg despite the SVV falling below 14% with isotonic boluses.

    Time frame: during surgery

  2. Number of bolus administrations of isotonic fluid

    For the MAP group, the number of administrations of 250 ml of isotonic fluid delivered in 10 minutes when MAP \< 65 mmHg For the SVV group, the number of administrations of 250 ml of isotonic fluid administered in 10 minutes when SVV≥ 14%

    Time frame: during surgery

  3. The Number of Hypotensive Episodes

    The number of times the MAP value falls below 65mmHg during surgery

    Time frame: during surgery

  4. Intraoperative Fluid Balance

    the difference between the amount of urine output and the amount of bleeding from the amount of fluid given

    Time frame: during surgery

  5. Plasma iNOS Levels

    difference in serum iNOS levels preoperatively and after removal of mammoplasty material

    Time frame: Up to 6 hours

  6. Lactate value

    Values measured by perioperative arterial blood gas analysis

    Time frame: Up to 6 hours

  7. Base deficit value

    Values measured by perioperative arterial blood gas analysis

    Time frame: Up to 6 hours

  8. Creatinine value

    Blood level is checked on the preoperative and postoperative 1st day

    Time frame: Preoperative and Postoperative 1st day

  9. Urea value

    Blood level is checked on the preoperative and postoperative 1st day

    Time frame: Preoperative and Postoperative 1st day

  10. Hemoglobin value

    Blood level is checked on the preoperative and postoperative 1st day

    Time frame: Preoperative and Postoperative 1st day

07

Study locations

1 of 1 sites recruiting
  • Istanbul University, Department of Anesthesiology
    Istanbul, Fatih 34093, Turkey
    Recruiting
08

References and documents

Publications

  • Li J, Ji FH, Yang JP. Evaluation of stroke volume variation obtained by the FloTrac/Vigileo system to guide preoperative fluid therapy in patients undergoing brain surgery. J Int Med Res. 2012;40(3):1175-81. doi: 10.1177/147323001204000338. PubMed 22906292 ↗
  • Anavi S, Tirosh O. iNOS as a metabolic enzyme under stress conditions. Free Radic Biol Med. 2020 Jan;146:16-35. doi: 10.1016/j.freeradbiomed.2019.10.411. Epub 2019 Oct 28. PubMed 31672462 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 23, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05733403
Lead sponsor
Istanbul University
Responsible party
Demet Altun (attending anesthesiologist, Istanbul University) — Principal investigator
First posted
Feb 17, 2023
Start date
Apr 1, 2022
Primary completion
Oct 20, 2023
Completion
Dec 1, 2023 (estimated)
Last update
Oct 23, 2023

Study contacts

Demet Altun Bingol, Assoc. Prof.
Contact
drdemetaltun@hotmail.com
902126318767
Ceren Yılmaz, Resident
principal investigator · Istanbul University
Demet Kıvanç, researcher
principal investigator · Istanbul University
Ali E Çamcı, Prof.
study director · Istanbul University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion